Published by Coherent Market Insights
Posted on September 20, 2021
Coherent Market Insights released a new market study on 2021-2027 Array Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Array Market Forecast till 2027*.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/4221
High prevalence of chronic diseases is expected to propel growth of the array market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
Moreover, approval and launch of new products is also expected to aid in growth of the market. For instance, in March 2020, Agilent Technologies Inc. launched Agilent GenetiSure Cyto microarrays for prenatal and postnatal research. Similarly, the company launched three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.
Accuracy of arrays in determining the presence of pathogens in cannabis is expected to offer lucrative growth opportunities for players in the global array market. For instance, according to a November 2019 study results released by PathogenDx, Inc., end-point PCR technologies such as Sequencing and DNA microarray are more accurate in determining the presence of pathogens in cannabis.
Among regions, Europe is expected to witness significant growth in the array market, owing to growing pharmaceutical sector. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe was valued at US$ 139, 287 million in 2000, which increased to US$ 284, 028 million (est.) in 2018.
The array market is witnessing several M&A activities. For instance, in December 2019, Oncology Pharma, Inc. signed a Letter of Intent to acquire at least a 50% stake in Diagnomics, Inc., a private CLIA certified & CAP accredited private molecular Genomics lab and provider of DNA microarrays, Next Generation Sequencing, and real-time PCR solutions
Competitive Analysis
Major players operating in the array market include, Affymetrix, Inc., Diagnomics, Inc., PathogenDx, Inc., Illumina, Inc., Naffymetrix Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation.
Major players operating in the array market are focused on R&D of new products to expand their product portfolio. For instance, in December 2019, PathogenDx, Inc. was awarded two US Patents for Tandem PCR + Microarray Hybridisation technology
Array Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Naffymetrix Inc., Illumina Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4221
Reasons to Purchase this Report
• Current and future of global Array Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Array Market Research Study are:
Request Here Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/4221
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post The array market is estimated to account for US$ 4,899.9 Mn in terms of value in 2020 and is expected to reach US$ 12,892.5 Mn by the end of 2027 | Coherent Market Insights appeared first on Gatorledger.
Coherent Market Insights released a new market study on 2021-2027 Array Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Array Market Forecast till 2027*.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/4221
High prevalence of chronic diseases is expected to propel growth of the array market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
Moreover, approval and launch of new products is also expected to aid in growth of the market. For instance, in March 2020, Agilent Technologies Inc. launched Agilent GenetiSure Cyto microarrays for prenatal and postnatal research. Similarly, the company launched three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.
Accuracy of arrays in determining the presence of pathogens in cannabis is expected to offer lucrative growth opportunities for players in the global array market. For instance, according to a November 2019 study results released by PathogenDx, Inc., end-point PCR technologies such as Sequencing and DNA microarray are more accurate in determining the presence of pathogens in cannabis.
Among regions, Europe is expected to witness significant growth in the array market, owing to growing pharmaceutical sector. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe was valued at US$ 139, 287 million in 2000, which increased to US$ 284, 028 million (est.) in 2018.
The array market is witnessing several M&A activities. For instance, in December 2019, Oncology Pharma, Inc. signed a Letter of Intent to acquire at least a 50% stake in Diagnomics, Inc., a private CLIA certified & CAP accredited private molecular Genomics lab and provider of DNA microarrays, Next Generation Sequencing, and real-time PCR solutions
Competitive Analysis
Major players operating in the array market include, Affymetrix, Inc., Diagnomics, Inc., PathogenDx, Inc., Illumina, Inc., Naffymetrix Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation.
Major players operating in the array market are focused on R&D of new products to expand their product portfolio. For instance, in December 2019, PathogenDx, Inc. was awarded two US Patents for Tandem PCR + Microarray Hybridisation technology
Array Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Naffymetrix Inc., Illumina Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4221
Reasons to Purchase this Report
• Current and future of global Array Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Array Market Research Study are:
Request Here Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/4221
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post The array market is estimated to account for US$ 4,899.9 Mn in terms of value in 2020 and is expected to reach US$ 12,892.5 Mn by the end of 2027 | Coherent Market Insights appeared first on Gatorledger.
Explore more articles in the Research Reports category
